Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.

Farrant J. et al, (2023), Heart

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.

Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.

Hundertmark MJ. et al, (2023), Circulation

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.

Jackson C. et al, (2023), Lancet Respir Med

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.

McAuley HJC. et al, (2023), EClinicalMedicine, 57

Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.

Astley JR. et al, (2023), J Magn Reson Imaging

Acute changes in myocardial tissue characteristics during hospitalization in patients with COVID-19.

Shanmuganathan M. et al, (2023), Front Cardiovasc Med, 10

Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19.

Daines L. et al, (2023), ERJ Open Res, 9

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Zheng B. et al, (2023), The Lancet Regional Health - Europe

Editorial: Post-COVID-19 cardiovascular sequelae.

Condurache D-G. et al, (2023), Front Cardiovasc Med, 10

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study

Finnigan LEM. et al, (2023), eClinicalMedicine

Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection.

Melhorn J. et al, (2023), Front Med (Lausanne), 10

Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants.

McCracken C. et al, (2022), Nat Commun, 13

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.

Liew F. et al, (2022), EBioMedicine

Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.

Vidula MK. et al, (2022), JACC Cardiovasc Imaging

Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study

Plekhanova T. et al, (2022), International Journal of Behavioral Nutrition and Physical Activity, 19

Differing Impact of Preterm Birth on the Right and Left Atria in Adulthood.

Schuermans A. et al, (2022), J Am Heart Assoc

Residual Lung Abnormalities Following COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID Study.

Stewart I. et al, (2022), Am J Respir Crit Care Med

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.

Hermida U. et al, (2022), Eur Heart J Cardiovasc Imaging

Long COVID: mechanisms, risk factors and recovery.

Astin R. et al, (2022), Exp Physiol

Load More

1
2
3
4
5

Include forthcoming?